482TiP Global, Phase 3 study of first-line durvalumab...

Annals of Oncology 2016 / 12 Vol. 27; Iss. suppl_9

482TiP Global, Phase 3 study of first-line durvalumab (MEDI4736) + tremelimumab vs standard of care platinum-based chemotherapy in advanced/metastatic NSCLC: NEPTUNE

Mok, T., Schmid, P., de Castro, G., Syrigos, K., Martin, C., Yamamoto, N., Arén, O., Arrieta, O., Gottfried, M., Jazieh, A.R., Ramlau, R., Timcheva, C., Trani, L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw594.046
Date:
December, 2016
File:
PDF, 57 KB
english, 2016
Conversion to is in progress
Conversion to is failed